Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRNB4 | P30926 | 3/20 | 0.67 |
| ▸ | CHRNA3 | P32297 | 3/20 | 0.67 |
| ▸ | CHRNA7 | P36544 | 3/20 | 0.67 |
| ▸ | CHRNB2 | P17787 | 3/20 | 0.67 |
| ▸ | CHRNA4 | P43681 | 3/20 | 0.67 |
| ▸ | CHRNA10 | Q9GZZ6 | 1/20 | 0.67 |
| ▸ | CHRNA9 | Q9UGM1 | 1/20 | 0.67 |
| ▸ | KCNA3 | P22001 | 1/20 | 0.61 |
| ▸ | ESR1 | P03372 | 3/20 | 0.59 |
| ▸ | MLNR | O43193 | 1/20 | 0.59 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.59 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.59 |
| ▸ | PGR | P06401 | 1/20 | 0.59 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.59 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.59 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.59 |
| ▸ | HTR1A | P08908 | 1/20 | 0.59 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.59 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.59 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phosphoric Acid SCHEMBL8154892 | 0.88 | CHRNB4 (0.56) | CHRNB4CHRNA3CHRNA7CHRNB2CHRNA4 | |
| Hydrochloric Acid SCHEMBL27474976 | 0.86 | CHRNB4 (0.53) | CHRNB4CHRNA3CHRNA7CHRNB2CHRNA4 | |
| Hydrochloric Acid SCHEMBL28604995 | 0.86 | CHRNB4 (0.53) | CHRNB4CHRNA3CHRNA7CHRNB2CHRNA4 | |
| Phosphoric Acid SCHEMBL8154895 | 0.85 | CHRNB4 (0.53) | CHRNB4CHRNA3CHRNA7CHRNB2CHRNA4 | |
| SCHEMBL9186723 | 0.83 | CHRNA7 (0.58) | CHRNB4CHRNA3CHRNA7CHRNB2CHRNA4 | |
| SCHEMBL13385235 | 0.80 | CHRNA7 (1.00) | CHRNB4CHRNA3CHRNA7CHRNB2CHRNA4 | |
| SCHEMBL22855771 | 0.80 | ALDH1A1 (0.59) | CHRNB4CHRNA3CHRNA7CHRNB2CHRNA4 | |
| Bephenium SCHEMBL44590 | 0.80 | CHRM2 (0.58) | CHRNB4CHRNA3CHRNA7CHRNB2CHRNA4 | |
| SCHEMBL9182298 | 0.80 | CHRNB4 (0.48) | CHRNB4CHRNA3CHRNA7CHRNB2CHRNA4 | |
| SCHEMBL27962 | 0.79 | KCNA3 (0.82) | CHRNB4CHRNA3CHRNA7CHRNB2CHRNA4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 70 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0549773-B1 | ETHER-CONTAINING QUATERNARY AMMONIUM SALTS | EASTMAN KODAK CO (US) | 1995-07-05 | — | — | EP | claimed |
| US-20240215891-A1 | Bio-Electrode Composition, Bio-Electrode, And Method For Manufacturing Bio-Electrode | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2024-07-04 | — | — | US | disclosed |
| US-20240215890-A1 | Bio-Electrode, Bio-Electrode Composition, And Method For Manufacturing Bio-Electrode | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2024-07-04 | — | — | US | disclosed |
| WO-2024072904-A2 | PURIFICATION OF NUCLEOTIDES | MODERNATX, INC. (US) | 2024-04-04 | — | — | WO | disclosed |
| EP-4309582-A1 | BIO-ELECTRODE COMPOSITION, BIO-ELECTRODE, AND METHOD FOR MANUFACTURING THE SAME | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2024-01-24 | — | — | EP | disclosed |
| US-11839700-B2 | Bio-electrode composition, bio-electrode, and method for manufacturing a bio-electrode | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2023-12-12 | — | — | US | disclosed |
| US-11783958-B2 | Conductive wiring material composition, conductive wiring substrate and method for producing conductive wiring substrate | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2023-10-10 | — | — | US | disclosed |
| US-11774853-B2 | Resist composition and patterning process | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2023-10-03 | — | — | US | disclosed |
| EP-3984456-B1 | BIO-ELECTRODE COMPOSITION, BIO-ELECTRODE, METHOD FOR MANUFACTURING BIO-ELECTRODE, POLYMER COMPOUND, AND COMPOSITE | SHINETSU CHEMICAL CO (JP) | 2023-08-23 | — | — | EP | disclosed |
| US-11733608-B2 | Resist composition and patterning process | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2023-08-22 | — | — | US | disclosed |
| EP-2751079-A1 | BIPHENYLCARBOXAMIDES AS ROCK KINASE INHIBITORS | Amakem NV (BE) | 2014-07-09 | — | — | EP | disclosed |
| US-20140187555-A1 | NOVEL SOFT PDE4 INHIBITORS | AMAKEM NV (BE) | 2014-07-03 | — | — | US | disclosed |
| EP-2742025-A1 | NOVEL SOFT PDE4 INHIBITORS | Amakem NV (BE) | 2014-06-18 | — | — | EP | disclosed |
| WO-2014068035-A1 | NOVEL ROCK INHIBITORS | AMAKEM NV (BE) | 2014-05-08 | — | — | WO | disclosed |
| WO-2013030366-A1 | NOVEL SOFT ROCK INHIBITORS | AMAKEM NV (BE) | 2013-03-07 | — | — | WO | disclosed |
| WO-2013030365-A1 | NOVEL ROCK KINASE INHIBITORS | AMAKEM NV (BE) | 2013-03-07 | — | — | WO | disclosed |
| WO-2013030367-A1 | BIPHENYLCARBOXAMIDES AS ROCK KINASE INHIBITORS | AMAKEM NV (BE) | 2013-03-07 | — | — | WO | disclosed |
| WO-2013021021-A1 | NOVEL SOFT PDE4 INHIBITORS | AMAKEM NV (BE) | 2013-02-14 | — | — | WO | disclosed |
| US-20080118970-A1 | Methods of adenovirus purification | KONZ JOHN O JR | 2008-05-22 | — | — | US | disclosed |
| US-7326555-B2 | Using domiphen bromide to selectively precipitate viral particles from DNA mixtures; ion echange chromatography | MERCK & CO., INC. (US) | 2008-02-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11733608-B2 | Resist composition and patterning process | HNRNPU, INSR, BICRA | CHRNB4 1527/4885CHRNA3 2820/4885CHRNA7 2834/4885 |
| US-20140187555-A1 | NOVEL SOFT PDE4 INHIBITORS | PDE4A, PDE4B, PDE12 | CHRNB4 1841/4885CHRNA3 2857/4885CHRNA7 3748/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.